SCHEMBL569725

SCHEMBL569725

O=C(c1ccccc1)C(F)(F)S(=O)(=O)O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 5/20 0.59
ALDH1A1 P00352 2/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
MLYCD O95822 2/20 0.42
TSHR P16473 3/20 0.41
CES2 O00748 2/20 0.41
DAO P14920 1/20 0.41
NAPRT Q6XQN6 1/20 0.41
SRC P12931 1/20 0.40
PTPN1 P18031 1/20 0.40
CYP3A4 P08684 2/20 0.38
MAPT P10636 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
CA2 P00918 2/20 0.38
CA4 P22748 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
POLB P06746 1/20 0.38
PARP1 P09874 1/20 0.38
CYP2C19 P33261 1/20 0.38
RECQL P46063 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14962761 0.86 TSHR (0.48) CES1ALDH1A1L3MBTL1TSHRMAPT
SCHEMBL14310498 0.83 CES1 (0.59) CES1ALDH1A1L3MBTL1MLYCDTSHR
SCHEMBL6877688 0.82 CES1 (0.57) CES1ALDH1A1L3MBTL1MLYCDTSHR
Benzoic Acid SCHEMBL17318230 0.77 TSHR (0.61) CES1ALDH1A1TSHRCES2DAO
SCHEMBL569646 0.76 TDP1 (0.47) CES1ALDH1A1L3MBTL1MLYCDTSHR
SCHEMBL437313 0.76 CES1 (0.50) CES1SRCPTPN1MAPTCA2
SCHEMBL11032447 0.75 CES1 (0.48) CES1ALDH1A1L3MBTL1MLYCDTSHR
SCHEMBL9772320 0.75 CES1 (0.48) CES1ALDH1A1L3MBTL1MLYCDTSHR
SCHEMBL7907262 0.75 CES1 (0.73) CES1ALDH1A1L3MBTL1MLYCDTSHR
SCHEMBL33083 0.75 CES1 (1.00) CES1ALDH1A1MLYCDTSHRCES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9708254-B2 Superacid functional compounds ARKEMA INC. (US) 2017-07-18 US disclosed
US-9708254-B2 Superacid functional compounds ARKEMA INC. (US) 2017-07-18 US disclosed
US-20130131201-A1 SUPERACID FUNCTIONAL COMPOUNDS ARKEMA INC. (US) 2013-05-23 US disclosed
US-20130131201-A1 SUPERACID FUNCTIONAL COMPOUNDS ARKEMA INC. (US) 2013-05-23 US disclosed
WO-2012018709-A2 SUPERACID FUNCTIONAL COMPOUNDS ARKEMA INC. (US) 2012-02-09 WO disclosed
WO-2008009815-A2 METHOD FOR PREPARING AROMATIC SULFONATES INSTITUT NATIONAL POLYTECHNIQUE DE GRENOBLE (FR) 2008-01-24 WO disclosed
WO-2008009815-A2 METHOD FOR PREPARING AROMATIC SULFONATES INSTITUT NATIONAL POLYTECHNIQUE DE GRENOBLE (FR) 2008-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130131201-A1 SUPERACID FUNCTIONAL COMPOUNDS AFF1, AFF2, AFF4 CES1 1107/4885ALDH1A1 1657/4885L3MBTL1 2827/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.